Yasser Aldhamen

Our research projects are focused on developing next-generation cancer immunotherapies by targeting specific mechanisms within our immune system. These innate immune pathways, orchestrated by immune cells such as T and NK cells with cancer-fighting capabilities, can be further enhanced through innovative genetic engineering strategies. One novel strategy is to encode antigens associated with cancer stem cells into a viral vector to elicit a potent immune response much like a vaccine, establishing durable tumour control and immune memory. This pioneering strategy may combat the spread and regrowth of particularly aggressive tumours.